The use of dietary urolithin A in cancer prevention or as adjuvant therapy is promising.

PMID: 

Mol Nutr Food Res. 2020 Jan 24:e1900390. Epub 2020 Jan 24. PMID: 31976617

Abstract Title: 

Gut metabolite, Urolithin A decreases Actin Polymerization and Migration in Cancer Cells.

Abstract: 

SCOPE: Urolithin A (UA) is a gut-derived metabolite from ellagic acid found in pomegranates, berries and nuts can down-regulate cell proliferation and migration. Cell proliferation and cell motility require actin reorganization which is under control of ras-related C3 botulinum toxin substrate 1 (Rac1) and p21 protein-activated kinase 1 (PAK1). The present study explored whether Urolithin A can modify actin cytoskeleton in cancer cells.METHODS: The effect of Urolithin A on globular over filamentous actin ratio was determined utilizing Western blotting, immunofluorescence and flow cytometry. Rac1 and PAK1 levels were measured by qRT-PCR and immunoblotting. As a result, a 24 hour treatment with Urolithin A (20μM) significantly decreased Rac1 and PAK1 transcript levels and activity, depolymerized actin and wound healing. The effect of Urolithin A on actin polymerization was mimicked by pharmacological inhibition of Rac1 and PAK1. The effect was also mirrored by knock down using siRNA.CONCLUSION: Urolithin A leads to disruption of Rac1 and Pak1 activity with subsequent actin depolymerization and migration. Thus, use of dietary Urolithin A in cancer prevention or as adjuvant therapy is promising. This article is protected by copyright. All rights reserved.

read more

Published by Taylor Mercado

Health Time is a blog talking about alternative medicines. And a blog founded by Taylor Mercado. She is a biologist and also a herbalist. This blog will help you and giving you tips regarding with herbal medicines.

Leave a comment

Design a site like this with WordPress.com
Get started